Skip to main content

toppbild-press-1551x278.jpg

Press

Interview with CEO Anna Ljung

Link to video »

All pressreleases
Regulatory

2020-03-27 | Press release

Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)

2020-03-23 | Press release

Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015

2020-03-23 | Press release

All patients in the European MOB-015 Phase 3 study have completed their last visit

2020-03-27 | Press release

Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)

2020-03-23 | Press release

Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015

2020-02-11 | Press release

Moberg Pharma AB Interim report October - December 2019

Read more press releases »

Latest report

2020-02-11 Moberg Pharma AB Interim report October - December 2019

Contact for press och media:

Anna Ljung, CEO
Phone: +46 8 522 307 08
Email: anna.ljung@mobergpharma.se

Subscribe

Calendar/presentations

Next calendar event: 2020-04-28 Extra General Shareholders Meeting